loading
前日終値:
$20.43
開ける:
$20.62
24時間の取引高:
127.60K
Relative Volume:
0.38
時価総額:
$1.05B
収益:
当期純損益:
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$19.75
$22.00
52週間の値動き範囲:
Value
$19.75
$22.00

City Therapeutics, Inc. Common Stock Stock (CTY) Company Profile

Name
名前
City Therapeutics, Inc. Common Stock
Name
セクター
Healthcare (1052)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
null
Name
最新のSEC提出書
Name
CTY's Discussions on Twitter

Compare CTY vs VRTX, REGN, MRNA, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CTY icon
CTY
City Therapeutics, Inc. Common Stock
20.77 1.05B 0 0 0 0.00
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
523.93 132.80B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
805.02 82.88B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
200.10 79.89B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
873.71 54.94B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
377.63 42.72B 5.76B 514.49M 1.10B 4.4813

City Therapeutics, Inc. Common Stock (CTY) 最新ニュース

pulisher
Oct 19, 2026

City Therapeutics Director Ron M Philip Awarded 22,649-Share Stock Option - Kalkine Media

Oct 19, 2026
pulisher
Oct 19, 2026

ARCH Venture Fund XII Converts Preferred Shares to Common Stock at City Therapeutics IPO - Kalkine Media

Oct 19, 2026
pulisher
Oct 19, 2026

City Therapeutics closes $230 million upsized IPO By Investing.com - Investing.com South Africa

Oct 19, 2026
pulisher
Oct 19, 2026

At its IPO close, City Therapeutics (CTY) saw ARCH buy 170,000 shares and convert preferred stock. - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

At the IPO closing, ARCH bought 170,000 City Therapeutics (CTY) shares at $18 each. - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

IPO conversion gives City Therapeutics (CTY) director John Maraganore 610,759 common shares. - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

Director receives 22,649 stock options with an $18 exercise price at City Therapeutics (CTY). - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

IPO closing fully vests 77,979 CEO options at City Therapeutics (CTY). - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

A director receives 22,649 City Therapeutics (CTY) options with an $18 exercise price. - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

Barry E. Greene acquires an option on 22,649 City Therapeutics (CTY) shares with an $18 exercise price. - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

City Therapeutics closes $230 million upsized IPO By Investing.com - Investing.com Canada

Oct 19, 2026
pulisher
Oct 19, 2026

A company developing medicines that silence genes brought in about $230 million before costs. - Stock Titan

Oct 19, 2026
pulisher
Oct 19, 2026

City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo Finance Singapore

Oct 19, 2026
pulisher
Oct 19, 2026

City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - GlobeNewswire

Oct 19, 2026
pulisher
Oct 18, 2026

City Therapeutics, Inc. (CTY) Company Information - Simply Wall Street

Oct 18, 2026
pulisher
Oct 17, 2026

City Therapeutics (CTY) director Barry E. Greene holds an option to buy 59,878 shares at $0.92 each. - Stock Titan

Oct 17, 2026
pulisher
Oct 17, 2026

A director’s City Therapeutics (CTY) holdings include an option for 135,611 shares at $5.36. - Stock Titan

Oct 17, 2026
pulisher
Oct 17, 2026

Director Ron M. Philip holds a $0.92 option on 59,878 City Therapeutics (CTY) shares - Stock Titan

Oct 17, 2026
pulisher
Oct 17, 2026

Medical chief holds options with $1.84 and $5.36 exercise prices at City Therapeutics (CTY). - Stock Titan

Oct 17, 2026
pulisher
Oct 17, 2026

CEO holds 1.06M shares in City Therapeutics (CTY), plus options priced at $0.92 and $5.36. - Stock Titan

Oct 17, 2026
pulisher
Oct 17, 2026

Holdings in City Therapeutics (CTY) include 2.72M common shares and convertible preferred stock. - Stock Titan

Oct 17, 2026
pulisher
Oct 17, 2026

Director Sara Nochur holds an option on 59,878 City Therapeutics (CTY) shares at a $0.92 exercise price. - Stock Titan

Oct 17, 2026
pulisher
Oct 15, 2026

City Therapeutics prices IPO at $18 per share, raising $200M - Investing.com

Oct 15, 2026
pulisher
Oct 15, 2026

A stock sale is expected to bring City Therapeutics about $200 million. - Stock Titan

Oct 15, 2026
pulisher
Oct 15, 2026

City Therapeutics (CTY) COO holds 534,511 shares plus options exercisable at $0.92 and $5.36. - Stock Titan

Oct 15, 2026

City Therapeutics, Inc. Common Stock (CTY) 財務データ

City Therapeutics, Inc. Common Stock (CTY) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

City Therapeutics, Inc. Common Stock (CTY) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
NELSEN ROBERT
Director
Oct 19 '26
Buy
18.00
170,000
3,060,000
13,692,507
$21.00
price up icon 9.38%
$3.19
price down icon 0.31%
$16.66
price down icon 2.34%
$11.46
price down icon 4.42%
VOR VOR
$18.26
price down icon 3.59%
$11.85
price down icon 3.97%
大文字化:     |  ボリューム (24 時間):